-
Signature
-
/s/ Ian C. Lofwall, Attorney-in-Fact
-
Issuer symbol
-
VVV
-
Transactions as of
-
20 Nov 2023
-
Net transactions value
-
-$164,186
-
Form type
-
4
-
Filing time
-
22 Nov 2023, 07:41:31 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VVV |
Common Stock |
Options Exercise |
|
+13,362 |
+84% |
|
29,204 |
20 Nov 2023 |
Direct |
F1 |
| transaction |
VVV |
Common Stock |
Tax liability |
$147,552 |
-4,223 |
-14% |
$34.94 |
24,981 |
20 Nov 2023 |
Direct |
|
| transaction |
VVV |
Common Stock |
Options Exercise |
$71,295 |
+3,500 |
+14% |
$20.37 |
28,481 |
20 Nov 2023 |
Direct |
F2 |
| transaction |
VVV |
Common Stock |
Tax liability |
$87,930 |
-2,498 |
-8.8% |
$35.20 |
25,983 |
20 Nov 2023 |
Direct |
F3 |
| holding |
VVV |
Common Stock |
|
|
|
|
|
3,041 |
20 Nov 2023 |
By 401(k) Plan |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VVV |
Performance Stock Units |
Options Exercise |
$0 |
-13,362 |
-100% |
$0.000000* |
0 |
20 Nov 2023 |
Common Stock |
13,362 |
|
Direct |
F1, F5 |
| transaction |
VVV |
FY 2019 Stock Appreciation Rights |
Options Exercise |
$0 |
-3,500 |
-100% |
$0.000000* |
0 |
20 Nov 2023 |
Common Stock |
3,500 |
$20.37 |
Direct |
F2, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: